HFG Advisors’s AbbVie ABBV Stock Holding History

HFG Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$542K	Buy	2,493 +1,573	+171%	+$349K	0.38%	56
2025 Q4	$210K	Hold	920	–	–	0.15%	103
2025 Q3	$213K	Buy	+920	New	+$187K	0.16%	95
2025 Q2	–	Sell	-1,059	Closed	-$222K	–	98
2025 Q1	$222K	Buy	+1,059	New	+$206K	0.19%	85
2024 Q4	–	Sell	-1,038	Closed	-$205K	–	94
2024 Q3	$205K	Buy	+1,038	New	+$194K	0.18%	95
2022 Q2	–	Sell	-1,494	Closed	-$242K	–	83
2022 Q1	$242K	Hold	1,494	–	–	0.28%	76
2021 Q4	$202K	Buy	+1,494	New	+$176K	0.23%	80

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HFG Advisors's ABBV Position: Q1 2026 in Review

HFG Advisors increased its AbbVie (ABBV) stake by 171% in Q1 2026, buying an estimated $349K and bringing the position to 2,493 shares worth $542K. The position accounts for 0.38% of the portfolio, ranked #56.

HFG Advisors first reported a position in ABBV in Q4 2021 and has held it in 7 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

HFG Advisors held 2,493 shares of AbbVie worth $542K as of Q1 2026.
HFG Advisors bought 1,573 AbbVie shares in Q1 2026, an estimated $349K.
AbbVie made up 0.38% of HFG Advisors's portfolio in Q1 2026, its #56 holding.
HFG Advisors first reported a position in AbbVie in Q4 2021 and has held it in 7 quarters since.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on HFG Advisors's 13F filing for Q1 2026, filed 8 May 2026.